GO:0140448 signaling receptor ligand precursor processing: Proteolytic Maturation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140448 signaling receptor ligand precursor processing describes the cleavage of a peptide bond in a precursor form of a signaling receptor ligand, converting it into the mature active ligand.
• This process is essential for activating ligands such as TGF-beta, BMP, TNF-alpha, and amphiregulin, which control cell fate, immunity, and tissue homeostasis.
• Proteolytic maturation is carried out by proprotein convertases and metalloproteases, and dysregulation is linked to cancer, inflammatory diseases, and bone disorders.
• Key genes involved include ADAM17, furin, TGFB1, BMP2, TNF, AREG, and their receptors, which are frequently studied using CRISPR knockout and knock-in models.
• Experimental approaches such as knockout, point mutation, and tagged knock-in cell models enable precise dissection of ligand maturation steps.
• Understanding GO:0140448 provides mechanistic insight into diseases where ligand processing is altered, including cancer, autoimmunity, and osteoclastogenesis.
Description
GO:0140448 signaling receptor ligand precursor processing is a biological process defined as the cleavage of a peptide bond in a precursor form of a signaling receptor ligand, resulting in the mature active form of the ligand. Many signaling ligands are initially synthesized as inactive precursors that require proteolytic processing to become functional. This maturation step is critical for controlling the timing, location, and intensity of receptor signaling, and it ensures that ligands are only activated when and where they are needed. The process is highly regulated and involves specific proteases that cleave precursor proteins at defined sites. For example, transforming growth factor-beta (TGF-beta) and bone morphogenetic proteins (BMPs) are produced as latent complexes that must be processed to release active ligands. Similarly, tumor necrosis factor-alpha (TNF-alpha) is initially expressed as a transmembrane precursor that is cleaved by ADAM17 to release soluble TNF-alpha. Amphiregulin, an epidermal growth factor receptor ligand, also requires proteolytic processing for activation. Researchers study GO:0140448 to understand how ligand maturation contributes to normal development and disease. Dysregulated processing can lead to excessive or insufficient signaling, contributing to cancer, inflammatory diseases, and bone disorders. The process is also important in immune regulation, as PD-1 axis signaling and T cell responses depend on proper ligand maturation. By investigating the genes and proteases involved, scientists can identify therapeutic targets and develop experimental models using CRISPR gene editing.
signaling receptor ligand precursor processing At A Glance
| GO ID | GO:0140448 |
|---|---|
| GO term | signaling receptor ligand precursor processing |
| Ontology | biological_process |
| Synonym | ligand maturation, signal maturation |
| Major function | Proteolytic cleavage of signaling receptor ligand precursors to generate mature active ligands |
| Cellular location | Secretory pathway, plasma membrane, extracellular space |
| Key enzymes | Proprotein convertases (e.g., furin), metalloproteases (e.g., ADAM17) |
| Example ligands | TGF-beta, BMPs, TNF-alpha, amphiregulin |
| Disease relevance | Cancer, inflammatory diseases, bone disorders, immune regulation |
What Is GO:0140448?
In simple terms, GO:0140448 signaling receptor ligand precursor processing is the molecular scissors step that cuts an inactive ligand precursor into its active form. According to the QuickGO definition, it is the cleavage of a peptide bond in a precursor form of a signaling receptor ligand, resulting in the mature (active) form of the ligand. This process is also known as ligand maturation or signal maturation. It is a biological process that ensures signaling molecules such as growth factors and cytokines are only active after specific proteolytic cleavage. Without this step, many ligands remain membrane-bound or latent and cannot bind to their receptors to trigger downstream signaling.
Why Is signaling receptor ligand precursor processing Important in Cell Biology?
GO:0140448 signaling receptor ligand precursor processing is fundamentally important because it controls the bioavailability of numerous signaling molecules that regulate cell proliferation, differentiation, apoptosis, and immune responses. Without precise proteolytic maturation, ligands remain inactive, leading to disrupted intercellular communication. This process is a key checkpoint in development and tissue homeostasis, and its dysregulation is implicated in a wide range of pathologies, including cancer, autoimmune diseases, and metabolic bone diseases. Understanding the molecular players and regulatory mechanisms of ligand maturation provides opportunities for therapeutic intervention and for designing better experimental models using CRISPR-based gene editing.
• Controls activation of growth factors such as TGF-beta and BMPs, which are essential for bone formation and development.
• Regulates TNF-alpha signaling, a central mediator of inflammation and a target for anti-TNF therapies.
• Modulates amphiregulin activity, which is involved in tissue repair and cancer progression.
• Influences immune cell function, including CD8+ T cell responses through PD-1 axis regulation.
• Affects osteoclast differentiation and bone loss, with implications for osteoporosis and inflammatory bone diseases.
• Provides a mechanism for spatial and temporal control of ligand availability, preventing inappropriate signaling.
• Dysregulation is linked to cancer, where excessive ligand processing promotes tumor growth and metastasis.
• Serves as a target for drug development, including protease inhibitors and antibody-based therapies.
• Enables researchers to study gene function using CRISPR knockout and knock-in models of processing enzymes and ligands.
• Helps explain how mutations in precursor cleavage sites can cause disease by altering ligand maturation.
What Happens During signaling receptor ligand precursor processing?
Synthesis and trafficking of ligand precursors
In simple terms: The cell builds an inactive version of the ligand and sends it to the right place.
Signaling receptor ligands such as TGF-beta, BMPs, TNF-alpha, and amphiregulin are initially synthesized as precursor proteins in the endoplasmic reticulum and transported through the secretory pathway. These precursors often contain pro-domains or transmembrane anchors that keep them inactive. For example, TGF-beta is secreted as part of a latent complex with latency-associated peptide, while TNF-alpha is initially expressed as a type II transmembrane protein. Proper folding and trafficking are prerequisites for subsequent proteolytic processing.
Proteolytic cleavage by convertases and metalloproteases
In simple terms: Enzymes act like molecular scissors to cut the precursor and release the active ligand.
The core of GO:0140448 is the cleavage of a peptide bond in the precursor. This is carried out by specific proteases. Proprotein convertases such as furin cleave TGF-beta and BMP precursors at multibasic sites, releasing mature ligands. Metalloproteases such as ADAM17 cleave transmembrane TNF-alpha and amphiregulin, shedding the ectodomain to produce soluble active ligands. The cleavage site and enzyme specificity determine the exact mature form and its biological activity.
Release and receptor binding
In simple terms: The active ligand is now free to bind its receptor and trigger a signal.
Once cleaved, the mature ligand is released from the cell surface or from latent complexes and can bind to its cognate receptor on target cells. For example, mature TGF-beta binds to TGF-beta receptors, initiating SMAD signaling. Soluble TNF-alpha binds to TNFR1 and TNFR2, activating NF-kB and MAPK pathways. Amphiregulin binds EGFR, promoting proliferation. This step is essential for signal transduction and is tightly regulated to prevent aberrant activation.
Regulation of processing
In simple terms: The cutting process is controlled so that ligands are activated only when needed.
Ligand precursor processing is regulated at multiple levels. Protease expression and activity can be induced by inflammatory signals, growth factors, or stress. For instance, ADAM17 activity is stimulated by phorbol esters and G-protein coupled receptor signaling. In the immune system, PD-1 axis signaling influences the maturation of ligands that maintain stem-like CD8+ T cells. Additionally, inhibitors such as TIMPs can block metalloprotease activity, providing another layer of control. Dysregulation of these regulatory mechanisms can lead to disease.
Biological outcomes of ligand maturation
In simple terms: The active ligand goes on to control cell behavior and tissue function.
Mature ligands produced by GO:0140448 drive diverse biological processes. TGF-beta and BMPs regulate osteoblast differentiation and bone formation. TNF-alpha mediates inflammation and immune responses. Amphiregulin supports tissue repair and can promote tumorigenesis. In osteoclastogenesis, stepwise cell fate decisions are influenced by signaling pathways that depend on proper ligand processing. STING-dependent interferon signatures can restrict osteoclast differentiation, highlighting crosstalk between immune and bone signaling. Thus, ligand maturation is central to development, homeostasis, and disease.
Key Genes Involved in GO:0140448 signaling receptor ligand precursor processing
The following genes encode ligands, proteases, and regulatory proteins that are directly involved in signaling receptor ligand precursor processing (GO:0140448).
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Encodes TGF-beta precursor that is proteolytically cleaved to release active TGF-beta | Studied in bone formation, fibrosis, and cancer |
| BMP2 | Encodes BMP2 precursor processed by convertases to active BMP2 | Key regulator of osteoblast differentiation and bone development |
| TNF | Encodes transmembrane TNF-alpha precursor cleaved by ADAM17 to soluble TNF-alpha | Central mediator of inflammation; target of anti-TNF biologics |
| AREG | Encodes amphiregulin precursor that is cleaved to release active EGFR ligand | Involved in tissue repair, cancer progression, and immune regulation |
| ADAM17 | Metalloprotease that cleaves TNF-alpha and amphiregulin precursors | Major sheddase; therapeutic target in inflammatory diseases and cancer |
| FURIN | Proprotein convertase that cleaves TGF-beta and BMP precursors | Essential for maturation of multiple growth factors |
| PDCD1 | Encodes PD-1, which influences T cell responses and ligand maturation in immune regulation | Target for cancer immunotherapy; linked to stem-like CD8+ T cells |
| CD274 | Encodes PD-L1, a ligand whose processing may affect PD-1 axis signaling | Studied in immune checkpoint regulation |
| TGFBR1 | Receptor for mature TGF-beta; downstream of ligand processing | Mediates TGF-beta signaling in bone and cancer |
| TGFBR2 | Receptor for mature TGF-beta; binds processed ligand | Mutations linked to cancer and connective tissue disorders |
| BMPR1A | Receptor for mature BMPs; activated after ligand processing | Important in bone and cartilage development |
| BMPR2 | Receptor for BMPs; requires processed ligand for activation | Associated with pulmonary arterial hypertension |
| TNFRSF1A | Receptor for soluble TNF-alpha; binds mature ligand | Mediates inflammatory signaling |
| TNFRSF1B | Receptor for TNF-alpha; binds mature ligand | Modulates immune responses |
| EGFR | Receptor for amphiregulin; activated by processed ligand | Target in cancer therapy |
| TIMP1 | Inhibitor of metalloproteases including ADAM17 | Regulates ligand processing and tissue remodeling |
| TIMP3 | Inhibitor of ADAM17 and other sheddases | Controls ligand maturation and inflammation |
| STING1 | Mediates interferon signaling that can restrict osteoclast differentiation | Links innate immunity to bone metabolism |
How Is signaling receptor ligand precursor processing Regulated?
The process of signaling receptor ligand precursor processing is regulated at multiple levels. Protease activity can be controlled by gene expression, post-translational modifications, and endogenous inhibitors such as TIMPs. Inflammatory cytokines and growth factors can induce ADAM17 and furin expression, creating positive feedback loops. The PD-1 axis in immune cells influences the maturation of ligands that maintain stem-like CD8+ T cells, thereby shaping adaptive immunity. Additionally, STING-dependent interferon signatures can restrict osteoclast differentiation, indirectly affecting bone-related ligand processing. These regulatory mechanisms ensure that ligand maturation is tightly coupled to physiological needs and can be disrupted in disease.
signaling receptor ligand precursor processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNF | Rheumatoid arthritis, inflammatory bowel disease | Knockout of ADAM17 cleavage site in TNF; point mutation to prevent shedding |
| AREG | Cancer, tissue repair | Overexpression of AREG in cancer cell lines; knockout of ADAM17 |
| TGFB1 | Fibrosis, cancer, bone disorders | Knock-in of cleavage-resistant TGFB1; knockout of furin |
| BMP2 | Bone development, osteoporosis | Point mutation in BMP2 cleavage site; knockout of BMP2 in osteoblasts |
| STING1 | Osteoclast differentiation, bone loss | Knockout of STING1 in osteoclast precursors; overexpression of STING1 |
Cancer
Dysregulated signaling receptor ligand precursor processing contributes to cancer by increasing the availability of growth factors such as TGF-beta and amphiregulin. Overexpression or enhanced cleavage of these ligands promotes tumor cell proliferation, survival, and metastasis. For example, elevated ADAM17 activity leads to increased shedding of TGF-alpha and amphiregulin, driving EGFR-dependent tumor growth. Targeting ligand maturation pathways is a potential therapeutic strategy in oncology.
Inflammatory and autoimmune diseases
TNF-alpha is a key mediator of inflammation, and its maturation from transmembrane precursor to soluble form is a critical step in inflammatory responses. Excessive ADAM17 activity results in elevated soluble TNF-alpha, contributing to rheumatoid arthritis, inflammatory bowel disease, and other autoimmune conditions. Anti-TNF therapies, such as infliximab and etanercept, target either the ligand or its receptor to reduce inflammation. Understanding the processing step helps in designing better inhibitors.
Bone disorders
TGF-beta and BMP signaling are essential for bone formation and remodeling. Defects in the proteolytic processing of these ligands can lead to impaired osteoblast differentiation and bone loss. Osteoclastogenesis is also influenced by signaling pathways that depend on proper ligand maturation, and STING-dependent interferon signatures can restrict osteoclast differentiation and bone loss. Thus, GO:0140448 is relevant to osteoporosis and inflammatory bone diseases.
Immune regulation and immunotherapy
The PD-1 axis maintains high-avidity stem-like CD8+ T cells, and ligand maturation may affect the availability of PD-L1 and other checkpoint ligands. Proper processing of immune-related ligands is necessary for balanced T cell responses. Dysregulation can lead to immune evasion by tumors or autoimmunity. Studying GO:0140448 in immune cells can inform the development of checkpoint inhibitors and adoptive T cell therapies.
From signaling receptor ligand precursor processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ADAM17-mediated cleavage of TNF-alpha drive inflammation? | ADAM17 knockout or point mutation in TNF cleavage site |
| What is the role of furin in TGF-beta maturation? | Furin knockout cell lines; knock-in of furin cleavage-resistant TGFB1 |
| How does amphiregulin processing affect cancer cell proliferation? | AREG overexpression and ADAM17 knockout in cancer cells |
| Does PD-1 axis regulate ligand maturation in CD8+ T cells? | PDCD1 knockout or overexpression in T cells |
| What is the impact of STING on osteoclast differentiation? | STING1 knockout and overexpression in osteoclast precursors |
| Can tagged knock-in reveal ligand processing dynamics? | Tagged knock-in of TGFB1 or TNF with fluorescent tag |
How to Study the signaling receptor ligand precursor processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of protease or ligand function | Study ADAM17 or furin in ligand maturation |
| Point mutation | Effect of specific cleavage site mutation | Prevent processing of TGF-beta or TNF |
| Knock-in tagging | Localization and processing of ligand precursors | Live-cell imaging of amphiregulin |
| Overexpression | Gain-of-function of ligand or protease | Cancer cell proliferation assays |
| Western blot | Presence of precursor vs. mature ligand | Validate cleavage in knockout cells |
| ELISA | Quantification of soluble ligand | Measure TNF-alpha or amphiregulin release |
| RNA-seq | Transcriptional changes upon processing | Identify downstream targets |
| Proteomics | Secreted ligand profile | Discover novel processed ligands |
CRISPR knockout and point mutation
CRISPR-Cas9 can be used to generate knockout cell lines for proteases such as ADAM17 or furin, or to introduce point mutations in cleavage sites of ligand precursors. These models allow researchers to determine the specific contribution of a cleavage event to ligand maturation and downstream signaling. For example, knocking out ADAM17 abolishes TNF-alpha shedding, while point mutations in the TGF-beta cleavage site prevent its release.
Knock-in and tagged knock-in
Knock-in of tagged versions of ligand precursors (e.g., GFP or HA tags) enables real-time tracking of processing and trafficking. Tagged knock-in models can be used with live-cell imaging to visualize cleavage events and ligand release. This approach is particularly useful for studying the spatiotemporal dynamics of GO:0140448 in response to stimuli.
Overexpression and rescue experiments
Overexpression of wild-type or mutant ligand precursors can reveal gain-of-function effects and help identify regulatory elements. Rescue experiments in knockout backgrounds can confirm specificity. For instance, overexpressing a cleavage-resistant TNF mutant in ADAM17 knockout cells can test whether shedding is required for inflammatory signaling.
Proteomics and secretome analysis
Mass spectrometry-based proteomics of conditioned media can identify mature ligands released by processing. Comparing secretomes of wild-type and protease-knockout cells reveals specific substrates and cleavage products. This unbiased approach can uncover novel ligands regulated by GO:0140448.
How CRISPR Can Be Used to Study GO:0140448 signaling receptor ligand precursor processing
Knockout
CRISPR knockout of genes encoding proteases (e.g., ADAM17, FURIN) or ligands (e.g., TNF, AREG) is a powerful way to study GO:0140448. Knockout cells lack the mature ligand and display altered signaling, which can be rescued by adding exogenous active ligand. This approach has been used to demonstrate the requirement of ADAM17 for TNF-alpha shedding and of furin for TGF-beta maturation.
Point Mutation
Introducing point mutations at the cleavage site of a ligand precursor prevents proteolytic processing while preserving the rest of the protein. This allows researchers to distinguish between effects of the precursor and the mature ligand. For example, a point mutation in the TNF cleavage site blocks soluble TNF-alpha release and results in a membrane-bound form, which can be used to study non-soluble TNF signaling.
Knock-in
Knock-in of tagged or fluorescently labeled ligand precursors enables visualization of processing in live cells. This is particularly useful for tracking the transition from precursor to mature ligand and for studying trafficking. Tagged knock-in models of TGF-beta or amphiregulin can reveal where and when cleavage occurs.
Overexpression
Overexpression of wild-type or mutant ligand precursors can be achieved by CRISPR activation or by lentiviral delivery. This approach is useful for studying gain-of-function effects and for producing large amounts of ligand for biochemical assays. Overexpression of amphiregulin in cancer cells promotes proliferation, and this effect is dependent on its processing.
How EDITGENE Supports signaling receptor ligand precursor processing Research
Researchers studying signaling receptor ligand precursor processing-related genes often need to determine whether a candidate gene is causally involved in ligand maturation or whether it is merely a bystander. This requires precise genetic models that can knockout, mutate, or tag the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations, from single gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for signaling receptor ligand precursor processing research.
Frequently Asked Questions About signaling receptor ligand precursor processing
What is GO:0140448 signaling receptor ligand precursor processing?
GO:0140448 is a biological process defined as the cleavage of a peptide bond in a precursor form of a signaling receptor ligand, resulting in the mature active form of the ligand.
What genes are involved in signaling receptor ligand precursor processing?
Key genes include ADAM17, FURIN, TGFB1, BMP2, TNF, AREG, and their receptors such as EGFR and TGFBR1.
Why is ligand precursor processing important?
It controls the activation of growth factors and cytokines, which regulate cell proliferation, differentiation, inflammation, and bone metabolism.
What diseases are linked to defects in ligand maturation?
Cancer, inflammatory diseases, autoimmune conditions, and bone disorders such as osteoporosis are associated with dysregulated ligand processing.
How is TNF-alpha processed?
TNF-alpha is initially a transmembrane precursor that is cleaved by ADAM17 to release soluble TNF-alpha, a key inflammatory mediator.
What role does furin play in ligand maturation?
Furin is a proprotein convertase that cleaves TGF-beta and BMP precursors, releasing mature ligands that control bone and tissue development.
Can CRISPR be used to study ligand precursor processing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the genes and steps involved in GO:0140448.
What is the difference between ligand maturation and signal maturation?
They are synonyms for the same process, GO:0140448, which refers to the proteolytic conversion of an inactive ligand precursor to its active form.
How does amphiregulin processing affect cancer?
Amphiregulin is cleaved by ADAM17 to activate EGFR, promoting cancer cell proliferation and survival; its overexpression is linked to tumor progression.
What experimental models are available for studying GO:0140448?
Knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screens, are available from EDITGENE to study ligand processing.
Conclusion
GO:0140448 signaling receptor ligand precursor processing is a fundamental biological process that controls the activation of numerous signaling molecules. Through proteolytic cleavage, inactive precursors are converted into mature ligands that regulate development, immunity, and tissue homeostasis. Dysregulation of this process contributes to cancer, inflammatory diseases, and bone disorders, making it an important area of research. Advances in CRISPR gene editing have enabled precise dissection of the genes and steps involved, and EDITGENE provides a comprehensive suite of services to support such studies. By understanding ligand maturation, researchers can identify new therapeutic targets and develop better experimental models.
References
- 1. Hor JL et al.. 2026. Inhibitory PD-1 axis maintains high-avidity stem-like CD8(+) T cells.. Nature 649(8095):194-204 PMID: 41299179
- 2. Berasain C et al.. 2014. Amphiregulin.. Semin Cell Dev Biol 28:31-41 PMID: 24463227
- 3. Chen G et al.. 2012. TGF-β and BMP signaling in osteoblast differentiation and bone formation.. Int J Biol Sci 8(2):272-88 PMID: 22298955
- 4. Horiuchi T et al.. 2010. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.. Rheumatology (Oxford) 49(7):1215-28 PMID: 20194223
- 6. Tsukasaki M et al.. 2020. Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution.. Nat Metab 2(12):1382-1390 PMID: 33288951
- 8. MacLauchlan S et al.. 2023. STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice.. Proc Natl Acad Sci U S A 120(15):e2210409120 PMID: 37023130
